- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Marketplace Renewals: State Efforts to Maximize Enrollment into Affordable Health Plan Options
For 2015, marketplaces' ability to conduct an effective renewal process for current enrollees is constrained by their information technology capacity, the short time period for open enrollment, and limited resources for outreach and consumer assistance.
The Congressional Budget Office has projected that the health insurance marketplaces will have 13 million people enrolled in 2015, but more recent estimates from HHS project only up to 9.9 million people will be enrolled. If either target is met, the majority of enrollees will be people who were covered in 2014 and re-enrolled. Though the marketplaces must make a significant investment to reach out to and enroll the uninsured, they must also focus on retaining those already enrolled.
For 2015, marketplaces’ ability to conduct an effective renewal process for current enrollees is constrained by their information technology capacity, the short time period for open enrollment (November 15, 2014, through February 15, 2015), and limited resources for outreach and consumer assistance.
Read the full study at The Urban Institute: http://urbn.is/12ShBQw
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
